OCUL
Ocular Therapeutix, IncCompany with tickers: OCUL
Market Cap
$2.16B
Shares Outstanding
218,960,358
CIK
1393434
CUSIP
67576A100
13F Activity (30d)
4 filings
3 filers
Website
Visit website
Investor Relations
Investor relations
Registered funds — mutual funds, ETFs and closed-end funds — whose latest Form N-PORT portfolio report holds this stock, matched by the stock's CUSIP. Each row is one fund position with its size, value and weight in that fund.
Funds holding OCUL
162 fund positions| Fund | Ticker | Balance | Value | % of Fund | Side | Reported | Open |
|---|---|---|---|---|---|---|---|
| Fidelity Growth Company Fund | — | 9,407,032 | $84,098,866 | 0.10% | Long | 2026-02-28 | |
| VANGUARD TOTAL STOCK MARKET INDEX FUND | — | 6,550,102 | $55,479,364 | 0.00% | Long | 2026-03-31 | |
| iShares Russell 2000 ETF | — | 4,599,969 | $38,961,737 | 0.05% | Long | 2026-03-31 | |
| Fidelity Growth Company K6 Fund | — | 2,635,532 | $23,561,656 | 0.10% | Long | 2026-02-28 | |
| Fidelity Series Growth Company Fund | — | 2,531,720 | $22,633,577 | 0.11% | Long | 2026-02-28 | |
| VANGUARD EXTENDED MARKET INDEX FUND | — | 1,949,505 | $16,512,307 | 0.02% | Long | 2026-03-31 | |
| iShares Russell 2000 Growth ETF | — | 1,531,041 | $12,967,917 | 0.11% | Long | 2026-03-31 | |
| T. Rowe Price New Horizons Fund, Inc. | — | 1,475,000 | $12,493,250 | 0.10% | Long | 2026-03-31 | |
| T. Rowe Price Health Sciences Fund, Inc. | — | 1,439,766 | $12,194,818 | 0.11% | Long | 2026-03-31 | |
| Select Pharmaceuticals Portfolio | — | 1,331,717 | $11,905,550 | 0.79% | Long | 2026-02-28 | |
| AB Small Cap Growth Portfolio | — | 1,029,122 | $9,642,873 | 0.33% | Long | 2026-04-30 | |
| T. Rowe Price Integrated U.S. Small-Cap Growth Equity Fund | — | 1,071,000 | $9,071,370 | 0.11% | Long | 2026-03-31 | |
| AB DISCOVERY GROWTH FUND, INC. | — | 885,803 | $8,299,974 | 0.31% | Long | 2026-04-30 | |
| VANGUARD RUSSELL 2000 INDEX FUND | — | 921,753 | $8,240,472 | 0.05% | Long | 2026-02-28 | |
| Fidelity Extended Market Index Fund | — | 891,821 | $7,972,880 | 0.02% | Long | 2026-02-28 | |
| Schwab U.S. Small-Cap ETF | — | 823,636 | $7,363,306 | 0.04% | Long | 2026-02-28 | |
| Select Biotechnology Portfolio | — | 784,000 | $7,008,960 | 0.13% | Long | 2026-02-28 | |
| Strategic Advisers Fidelity U.S. Total Stock Fund | — | 736,950 | $6,588,333 | 0.00% | Long | 2026-02-28 | |
| State Street(R) SPDR(R) S&P(R) Pharmaceuticals ETF | — | 621,423 | $5,263,453 | 1.71% | Long | 2026-03-31 | |
| Artisan International Small-Mid Fund | — | 559,675 | $4,740,447 | 0.18% | Long | 2026-03-31 | |
| Select Health Care Portfolio | — | 494,535 | $4,421,143 | 0.07% | Long | 2026-02-28 | |
| VANGUARD HEALTH CARE INDEX FUND | — | 478,485 | $4,277,656 | 0.02% | Long | 2026-02-28 | |
| iShares U.S. Pharmaceuticals ETF | — | 486,759 | $4,122,849 | 0.41% | Long | 2026-03-31 | |
| Schwab Small-Cap Index Fund | — | 412,396 | $3,864,151 | 0.05% | Long | 2026-04-30 | |
| EQ/AB Small Cap Growth Portfolio | — | 410,791 | $3,479,400 | 0.18% | Long | 2026-03-31 | |
| abrdn Healthcare Investors | HQH | 376,318 | $3,187,413 | 0.28% | Long | 2026-03-31 | |
| BlackRock Advantage Small Cap Core Fund | — | 333,380 | $2,980,417 | 0.07% | Long | 2026-02-27 | |
| Allspring Small Company Growth Fund | — | 303,716 | $2,845,819 | 0.55% | Long | 2026-04-30 | |
| SmallCap Growth Fund I | — | 303,709 | $2,845,753 | 0.12% | Long | 2026-04-30 | |
| Fidelity Total Market Index Fund | — | 314,521 | $2,811,818 | 0.00% | Long | 2026-02-28 | |
| Master Small Cap Index Series | — | 306,197 | $2,593,489 | 0.05% | Long | 2026-03-31 | |
| BlackRock Health Sciences Opportunities Portfolio | — | 258,781 | $2,313,502 | 0.04% | Long | 2026-02-27 | |
| Fidelity Series Total Market Index Fund | — | 248,322 | $2,219,999 | 0.00% | Long | 2026-02-28 | |
| Nuveen Small Cap Blend Index Fund | — | 225,988 | $2,117,508 | 0.05% | Long | 2026-04-30 | |
| U.S. MICRO CAP PORTFOLIO | — | 224,999 | $2,108,241 | 0.03% | Long | 2026-04-30 | |
| Optimum Small-Mid Cap Growth Fund | — | 234,547 | $1,986,613 | 0.26% | Long | 2026-03-31 | |
| iShares Core S&P Total U.S. Stock Market ETF | — | 231,968 | $1,964,769 | 0.00% | Long | 2026-03-31 | |
| EQ/2000 Managed Volatility Portfolio | — | 194,007 | $1,643,239 | 0.05% | Long | 2026-03-31 | |
| abrdn Life Sciences Investors | HQL | 182,062 | $1,542,065 | 0.27% | Long | 2026-03-31 | |
| VANGUARD RUSSELL 2000 GROWTH INDEX FUND | — | 170,051 | $1,520,256 | 0.11% | Long | 2026-02-28 | |
| Nuveen Equity Index Fund | — | 154,181 | $1,444,676 | 0.00% | Long | 2026-04-30 | |
| Fidelity Small Cap Growth Index Fund | — | 142,921 | $1,210,541 | 0.11% | Long | 2026-03-31 | |
| U.S. SMALL CAP PORTFOLIO | — | 128,124 | $1,200,522 | 0.01% | Long | 2026-04-30 | |
| Fidelity Nasdaq Composite Index Fund | — | 132,619 | $1,185,614 | 0.01% | Long | 2026-02-28 | |
| JPMorgan U.S. Small Company Fund | — | 139,065 | $1,177,881 | 0.13% | Long | 2026-03-31 | |
| T.Rowe Price Small Cap Growth Portfolio | — | 134,200 | $1,136,674 | 0.11% | Long | 2026-03-31 | |
| LVIP SSGA Small-Cap Index Fund | — | 123,200 | $1,043,504 | 0.05% | Long | 2026-03-31 | |
| Empower Small Cap Growth Fund | — | 119,028 | $1,008,167 | 0.44% | Long | 2026-03-31 | |
| VANGUARD BALANCED INDEX FUND | — | 116,488 | $986,653 | 0.00% | Long | 2026-03-31 | |
| Schwab Total Stock Market Index Fund | — | 104,198 | $976,335 | 0.00% | Long | 2026-04-30 |
Showing 1–50 of 162 positions